LABIANA HEALTH S.A.EO-10 Total Liabilities
LABIANA HEALTH S.A.EO-10 total liabilities. Based on the latest financial reports, LABIANA HEALTH S.A.EO-10 (8RK) has total liabilities worth €52.79 Million EUR (≈ $61.71 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check LABIANA HEALTH S.A.EO-10 (8RK) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of LABIANA HEALTH S.A.EO-10 (2021–2025)
Total liabilities of LABIANA HEALTH S.A.EO-10 from 2021 to 2025. This chart illustrates how LABIANA HEALTH S.A.EO-10's total liabilities have evolved over time, based on quarterly financial data.
LABIANA HEALTH S.A.EO-10 Competitors by Total Liabilities
The table below lists competitors of LABIANA HEALTH S.A.EO-10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sietel Ltd
AU:SSL
|
Australia | AU$9.16 Million |
|
Quartiers Properties AB
ST:QUART
|
Sweden | Skr218.07 Million |
|
GenoFocus Inc
KQ:187420
|
Korea | ₩82.66 Billion |
|
Bluebird bio Inc
NASDAQ:BLUE
|
USA | $353.82 Million |
|
Upsales Technology AB
ST:UPSALE
|
Sweden | Skr81.56 Million |
|
Chin Yang Chem
KO:051630
|
Korea | ₩21.85 Billion |
|
Indonesia Energy
NYSE MKT:INDO
|
USA | $3.28 Million |
|
Digihost Technology Inc
V:DGHI
|
Canada | CA$12.34 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down LABIANA HEALTH S.A.EO-10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is LABIANA HEALTH S.A.EO-10's balance sheet.
Liquidity & Leverage Metrics
LABIANA HEALTH S.A.EO-10 Total Liabilities Ratios Explained
LABIANA HEALTH S.A.EO-10 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 10.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.92 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LABIANA HEALTH S.A.EO-10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LABIANA HEALTH S.A.EO-10 (2021–2025)
The table below shows the annual total liabilities of LABIANA HEALTH S.A.EO-10 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €52.79 Million ≈ $61.71 Million |
+6.78% |
| 2024-12-31 | €49.43 Million ≈ $57.79 Million |
-11.28% |
| 2023-12-31 | €55.72 Million ≈ $65.14 Million |
+3.43% |
| 2022-12-31 | €53.87 Million ≈ $62.98 Million |
-5.23% |
| 2021-12-31 | €56.84 Million ≈ $66.46 Million |
-- |
About LABIANA HEALTH S.A.EO-10
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, North America, and internationally. It offers anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional products, metabolism regulators, and vitamin products. The company also provides sterile and lyophilized dosage f… Read more